» Articles » PMID: 26478753

Influences of Diet and the Gut Microbiome on Epigenetic Modulation in Cancer and Other Diseases

Overview
Publisher Biomed Central
Specialty Genetics
Date 2015 Oct 20
PMID 26478753
Citations 125
Authors
Affiliations
Soon will be listed here.
Abstract

Epigenetic modulation of gene activity occurs in response to non-genetic factors such as body weight status, physical activity, dietary factors, and environmental toxins. In addition, each of these factors is thought to affect and be affected by the gut microbiome. A primary mechanism that links these various factors together in mediating control of gene expression is the production of metabolites that serve as critical cofactors and allosteric regulators of epigenetic processes. Here, we review the involvement of the gut microbiota and its interactions with dietary factors, many of which have known cellular bioactivity, focusing on particular epigenetic processes affected and the influence they have on human health and disease, particularly cancer and response to treatment. Advances in DNA sequencing have expanded the capacity for studying the microbiome. Combining this with rapidly improving techniques to measure the metabolome provides opportunities to understand complex relationships that may underlie the development and progression of cancer as well as treatment-related sequelae. Given broad reaching and fundamental biology, both at the cellular and organismal levels, we propose that interactive research programs, which utilize a wide range of mutually informative experimental model systems-each one optimally suited for answering particular questions-provide the best path forward for breaking ground on new knowledge and ultimately understanding the epigenetic significance of the gut microbiome and its response to dietary factors in cancer prevention and therapy.

Citing Articles

The Role of Gut Microbiota in the Onset and Progression of Obesity and Associated Comorbidities.

Enache R, Profir M, Rosu O, Cretoiu S, Gaspar B Int J Mol Sci. 2024; 25(22).

PMID: 39596385 PMC: 11595101. DOI: 10.3390/ijms252212321.


Pathogenesis and therapeutic strategies for cancer-related depression.

Liu M, Yan R, Lu S, Zhang P, Xu S Am J Cancer Res. 2024; 14(9):4197-4217.

PMID: 39417166 PMC: 11477823. DOI: 10.62347/WVVG5364.


From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies.

Gharib E, Robichaud G Int J Mol Sci. 2024; 25(17).

PMID: 39273409 PMC: 11395697. DOI: 10.3390/ijms25179463.


α-Hemolysin from Staphylococcus aureus Changes the Epigenetic Landscape of Th17 Cells.

Pastwinska J, Karwaciak I, Karas K, Salkowska A, Chalaskiewicz K, Strapagiel D Immunohorizons. 2024; 8(9):606-621.

PMID: 39240270 PMC: 11447695. DOI: 10.4049/immunohorizons.2400061.


Early-life risk factors which govern pro-allergic immunity.

Ptaschinski C, Gibbs B Semin Immunopathol. 2024; 46(3-4):9.

PMID: 39066790 PMC: 11283399. DOI: 10.1007/s00281-024-01020-x.


References
1.
Maslowski K, Vieira A, Ng A, Kranich J, Sierro F, Yu D . Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 2009; 461(7268):1282-6. PMC: 3256734. DOI: 10.1038/nature08530. View

2.
Vaahtovuo J, Munukka E, Korkeamaki M, Luukkainen R, Toivanen P . Fecal microbiota in early rheumatoid arthritis. J Rheumatol. 2008; 35(8):1500-5. View

3.
Peserico A, Simone C . Physical and functional HAT/HDAC interplay regulates protein acetylation balance. J Biomed Biotechnol. 2010; 2011:371832. PMC: 2997516. DOI: 10.1155/2011/371832. View

4.
Mallegol J, van Niel G, Heyman M . Phenotypic and functional characterization of intestinal epithelial exosomes. Blood Cells Mol Dis. 2005; 35(1):11-6. DOI: 10.1016/j.bcmd.2005.04.001. View

5.
Selkrig J, Wong P, Zhang X, Pettersson S . Metabolic tinkering by the gut microbiome: Implications for brain development and function. Gut Microbes. 2014; 5(3):369-80. PMC: 4153776. DOI: 10.4161/gmic.28681. View